Comparison of Ranolazine and Trimetazidine on Glycemic Status in Diabetic Patients with Coronary Artery Disease – A Randomized Controlled Trial

Introduction: Cardiovascular diseases have become the leading cause of death around the globe and diabetes mellitus (DM) is considered to be a coronary artery disease (CAD) risk equivalent. Ranolazine, an anti anginal drug has been found to reduce Glycated haemoglobin (HbA(1c)) in diabetes patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Diagn Res
Hlavní autoři: Sandhiya, Selvarajan, Dkhar, Steven Aibor, Pillai, Ajith Ananthakrishna, George, Melvin, Jayaraman, Balachander, Chandrasekaran, Adithan
Médium: Artigo
Jazyk:Inglês
Vydáno: JCDR Research and Publications (P) Limited 2015
Témata:
Internal Medicine Section
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4347105/
https://ncbi.nlm.nih.gov/pubmed/25738014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2015/10594.5448
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky